Ledger.Open graph →
SEC Form D · filed November 7, 2023

Aligos Therapeutics, Inc

Offering
$92.2M
Sold
$92.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Jack A. Nielsen · South San Francisco, CADirectorLucinda A. Quan · South San Francisco, CAExecBridget P. Martell · South San Francisco, CADirectorLawrence M. Blatt · South San Francisco, CAExec · DirectorPeter A. Hirth · South San Francisco, CADirectorJames P. Scopa · South San Francisco, CADirectorCarole P. Nuechterlein · South San Francisco, CADirectorLeonid Beigelman · South San Francisco, CAExec · DirectorLesley A. Calhoun · South San Francisco, CAExecJulian P. Symons · South San Francisco, CAExecDavid C. Schwab · Palo Alto, CAExecCarole P. Nuechterlein · South San Francisco, CADirectorBradley N. Rothman · New York, NYDirectorLesley A. Calhoun · South San Francisco, CAExecLawrence M. Blatt · South San Francisco, CAExec · DirectorAlice H. Vilma · New York, NYDirectorJames P. Scopa · South San Francisco, CADirectorCaoimhghin O'Donnell · Luxembourg, LuxembourgExec · DirectorBridget P. Martell · South San Francisco, CADirectorCarla A. Harris · New York, NYExecMatthew A. Mcclure · South San Francisco, CAExecHernan Kazah · Montevideo, X3DirectorAndre Penha · Sao Paulo/SP, GuernseyDirectorTony Wood · Vancouver, British Columbia, CanadaExecWilliam Howald · Vancouver, British Columbia, CanadaExecAndrew Pollard · Vancouver, British Columbia, CanadaExec · DirectorJohn Seaberg · Vancouver, British Columbia, CanadaExec · DirectorAnindya Bose · Alpharetta, GAExecOrville Gordon · Alpharetta, GADirectorRich Cannon · Alpharetta, GADirectorLarry Mohl · Alpharetta, GADirectorMatthew A. Mcclure · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗